We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Matthias Rieker An arbitration panel ordered Wells Fargo & Co.'s (WFC) retail brokerage unit to pay a retired real-estate broker $1.8 million for losses tied to investments in soda and...
SOUTH SAN FRANCISCO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (NASDAQ:PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced...
Ronald A. Martell Named Chief Executive Officer Michael S. Perry, DVM, Ph.D., Named President and Chief Medical Officer SOUTH SAN FRANCISCO, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Poniard...
SOUTH SAN FRANCISCO, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (NASDAQ:PARD) today provided an overview of its 2010 corporate, clinical and regulatory goals for...
-- Company to Host Conference Call and Webcast Today at 8:00 a.m. ET -- SOUTH SAN FRANCISCO, Calif., Nov. 16 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (NASDAQ:PARD) today announced...
SOUTH SAN FRANCISCO, Calif., Nov. 15 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (NASDAQ:PARD) today announced that the Company will hold a teleconference and webcast at 8:00 a.m...
- Conference Call Today at 5:00 p.m. Eastern Time - SOUTH SAN FRANCISCO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (NASDAQ:PARD), a biopharmaceutical company focused...
SOUTH SAN FRANCISCO, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (NASDAQ:PARD), a biopharmaceutical company focused on oncology, today announced that it will hold a...
-- Event Enables Overall Survival Analysis of Registration SPEAR Trial -- SOUTH SAN FRANCISCO, Calif., Sept. 15 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (NASDAQ:PARD) today...
SOUTH SAN FRANCISCO, Calif., July 29 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (NASDAQ:PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
26 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 196 | 0.0001 | CS |
52 | 9.9E-5 | 9900 | 1.0E-6 | 0.000101 | 1.0E-6 | 3236 | 2.311E-5 | CS |
156 | -0.0099 | -99 | 0.01 | 0.01 | 1.0E-6 | 1642 | 3.654E-5 | CS |
260 | -0.0386 | -99.7416020672 | 0.0387 | 0.122 | 1.0E-6 | 4403 | 0.04699613 | CS |
Symbol | Price | Vol. |
---|---|---|
AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0.00275 (0.00%) | 51.06M |
GTEHGenTech Holdings Inc (CE) | US$ 0.000001 (0.00%) | 48.25M |
HMBLHUMBL Inc (PK) | US$ 0.0002 (-33.33%) | 42.65M |
CBGLCannabis Global Inc (PK) | US$ 0.00015 (50.00%) | 41.81M |
GTVHGolden Triangle Ventures Inc (PK) | US$ 0.0008 (33.33%) | 41.61M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions